AbbVie Inc(NYSE:ABBV) 
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the...
Website: http://www.abbvie.com
Founded: 2013
Full Time Employees: 50,000 (Dec 2022)
CEO: Richard Gonzalez
Sector: Healthcare
Industry: Drug Manufacturers-General
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 199.97
H 199.97
L 186.17
C 186.85
V 13,498,238
10EMA 186.85
20EMA 186.85
60EMA 186.85
120EMA 186.85
250EMA 186.85